Ignite Creation Date:
2024-05-06 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 2:32 PM
Study NCT ID:
NCT05368155
Status:
COMPLETED
Last Update Posted:
2023-03-03
First Post:
2022-05-03
Brief Title:
Chronic Pelvic Pain and Education Skills Training for Women Veterans
Sponsor:
Baylor College of Medicine
Organization:
Baylor College of Medicine
Study Overview
Official Title:
Chronic Pelvic Pain and Education Skills Training for Women Veterans
Status:
COMPLETED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Chronic pelvic pain CPP is a debilitating condition that disproportionately affects women Veterans 25 vs 16 of civilian women Predisposing factors include higher rates of strenuous physical activity during military service duty-related injuries psychiatric distress and sexual trauma CPP is associated with a high burden of illness disability and economic costs estimated at 58 billion in annual health care expenditures
Multimodal interdisciplinary approaches are emphasized in the treatment of CPP Psychological interventions are essential for optimizing pain self-management for CPP Psychosocial factors are known to affect pain intensity and recovery Women Veterans report higher rates of depression and anxiety with CPP that leads to greater disability and poorer quality of life Cognitive and behavioral therapies such as Acceptance and Commitment Therapy ACT are effective options for pain self-management Barriers to effective pain treatment are high attrition and non-adherence Additionally women Veterans prefer treatments that address their gender-specific needs Gender-specific services remain limited in the Veterans Health Administration VHA
In line with VHAs priorities to expand womens health care this study implements ACT in a brief intervention format to address a highly prevalent reproductive health issue among women Veterans ACT is transdiagnostic and thus provides a unified approach to the treatment of co-occurring disorders such as chronic pain depression and anxiety Brief workshop formats increase treatment completion and patient engagement This study seeks to adapt an existing 1-day ACT workshop for use in VHA integrated primary care PCMHI and specialty medical settings with women veterans experiencing CPP Primary outcomes are feasibility and acceptability of the adapted intervention
Multimodal interdisciplinary approaches are emphasized in the treatment of CPP Psychological interventions are essential for optimizing pain self-management for CPP Psychosocial factors are known to affect pain intensity and recovery Women Veterans report higher rates of depression and anxiety with CPP that leads to greater disability and poorer quality of life Cognitive and behavioral therapies such as Acceptance and Commitment Therapy ACT are effective options for pain self-management Barriers to effective pain treatment are high attrition and non-adherence Additionally women Veterans prefer treatments that address their gender-specific needs Gender-specific services remain limited in the Veterans Health Administration VHA
In line with VHAs priorities to expand womens health care this study implements ACT in a brief intervention format to address a highly prevalent reproductive health issue among women Veterans ACT is transdiagnostic and thus provides a unified approach to the treatment of co-occurring disorders such as chronic pain depression and anxiety Brief workshop formats increase treatment completion and patient engagement This study seeks to adapt an existing 1-day ACT workshop for use in VHA integrated primary care PCMHI and specialty medical settings with women veterans experiencing CPP Primary outcomes are feasibility and acceptability of the adapted intervention
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None